Yikon Genomics, a reproductive health-focused biotech firm, announces on Monday that it has completed RMB220 million (US$31.3 million) in a series C funding round led by venture capital firm Jinhe Capital under independent clinical laboratory KingMed Diagnostics.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?